Filgotinib Intermediate Synthesis JAK1 Inhibitor CAS 1142943-96-1

Category:Intermediates > Chiral Intermediates
Product Name:Filgotinib Intermediate Synthesis JAK1 Inhibitor CAS 1142943-96-1
CAS No.:1142943-96-1
Standard:In-house Standards
Price(USD):0.00
Company:TAIZHOU VOLSEN CHEMICAL CO.,LTD.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia

  • Sample Provided: no

    Cyclopropanecarboxylic Acid (5-Bromo-[1,2,4]Triazolo[1,5-a]Pyridin-2-yl)-Amide is another primary intermediates for Filgotinib (GLPG0634). We can offer a range of high quality Filgotinib Intermediates CAS 1142943-96-1 and related production. Our monthly capacity can meet customers needs. We offer Filgotinib Intermediates CAS NO 1142943-96-1 used in synthesis Filgotinib, and the offered range is highly acclaimed by clients. We can offer Filgotinib intermediates 1142943-96-1 available in various size of packaging to meet the specific requirements of our clients.

    Thera. Category: JAK Inhibitor

    Cas No.: 1142943-96-1

    Synonym: cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide;filgotinib intermediate

    1142943-96-1

    Molecular Formula: C10H9BrN4O

    Molecular Weight:281.10866

    Assay: ≥99.%

    Packing: Export worthy packing

    lMaterial Safety Data Sheet: Available on request

    Usage: Filgotinib (GLPG0634) Intermediates

    Related Product:
    CAS 1206161-97-8, Filgotinib (GLPG0634)
    CAS 59801-62-6, THIOMORPHOLINE 1,1-DIOXIDE HYDROCHLORIDE
    CAS 1142943-96-1, Cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide

Send your message to this supplier
  • From:
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service